How much life expectancy can Captopril (ACE inhibitor) add?

Based on population-weighted modelling, Captopril (ACE inhibitor) is associated with an estimated +1.0 years of life expectancy on average. Individual results depend on baseline health, adherence level, and age of intervention.

What is the evidence score for Captopril (ACE inhibitor)?

Captopril (ACE inhibitor) has an overall evidence score of 68/100 on Stacking Years, based on a weighted combination of 4 peer-reviewed studies (85% weight) and expert consensus (15% weight).

Which longevity experts recommend Captopril (ACE inhibitor)?

Captopril (ACE inhibitor) is endorsed or discussed by longevity experts including Peter Attia, MD, Brian Kennedy, PhD, Valter Longo, PhD. See their full protocols and citations on Stacking Years.

Is Captopril (ACE inhibitor) safe?

Captopril (ACE inhibitor) is a pharmaceutical. Safety depends on individual health status, dosing, and interactions with medications. Always consult a qualified healthcare provider before starting any new health protocol.

Captopril (ACE inhibitor)

Estimated longevity benefit: +1.0 years. Evidence score: 68/100.

Captopril is an ACE inhibitor that relaxes blood vessels by blocking the renin-angiotensin system, thereby reducing cardiovascular workload and systemic inflammation. Its unique ability to extend both median and maximum lifespan in animal models suggests that vascular preservation is a primary target for slowing systemic aging.